ACTINIUM PHARMACEUTICALS, INC. Increase (Decrease) in Other Operating Assets and Liabilities, Net
ACTINIUM PHARMACEUTICALS, INC. (ATNM) reported Increase (Decrease) in Other Operating Assets and Liabilities, Net of $315.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingCapitalNet · last filed 2021-03-31
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2020 was $315.00K, a 14.55% increase from fiscal 2019.
- ACTINIUM PHARMACEUTICALS, INC. increase (decrease) in other operating assets and liabilities, net for fiscal 2019 was $275.00K.
| Period end | Increase (Decrease) in Other Operating Assets and Liabilities, Net 12 month |
|---|---|
| 2020-12-31 | $315.00K 10-K · filed 2021-03-31 |
| 2019-12-31 | $275.00K 10-K · filed 2021-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |